Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-14

FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrylex) from Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NICORETTE ORIGINAL (NICOTINE POLACRILEX)

Snippet

SUPPL AP for NICORETTE ORIGINAL (NICOTINE POLACRILEX)